ALB and erythrocyte disorder: The composite measures used in our analysis were constructed using clinical markers of metabolic health (glucose), kidney and liver function (creatinine, albumin, alkaline phosphatase), anemia and/or red blood cell disorders (mean cell volume, red blood cell distribution width), and immune function and inflammation (CRP, lymphocyte percent, white blood cell count).